We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.21B
AUM Growth
-$220M
Cap. Flow
+$134M
Cap. Flow %
11.11%
Top 10 Hldgs %
68.51%
Holding
46
New
2
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NET icon
Cloudflare
NET
+$78.5M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$51.4M
3
XENE icon
Xenon Pharmaceuticals
XENE
+$3.97M
4
MRSN
Mersana Therapeutics
MRSN
+$202K
5
TRVI icon
Trevi Therapeutics
TRVI
+$62.8K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 90.68%
2 Technology 6.97%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
26
Liquidia Corp
LQDA
$7.46B
$8.85M 0.73%
2,486,062
– –
CSBR icon
27
Champions Oncology
CSBR
$80M
$8.83M 0.73%
1,562,500
– –
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$8.76M 0.73%
956,255
– –
LXRX icon
29
Lexicon Pharmaceuticals
LXRX
$1.03B
$7.17M 0.59%
2,382,286
– –
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$693M
$6.07M 0.5%
324,315
– –
VRNA
31
DELISTED
Verona Pharma
VRNA
$5.57M 0.46%
1,219,674
– –
XENE icon
32
Xenon Pharmaceuticals
XENE
$6.02B
$5.43M 0.45%
602,663
+419,909
+230% +$3.97M
SURF
33
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$4.71M 0.39%
3,315,149
– –
KA
34
DELISTED
Kineta, Inc. Common Stock
KA
$4.7M 0.39%
39,691
– –
BE icon
35
Bloom Energy
BE
$64.3B
$4.33M 0.36%
1,333,333
– –
XFOR icon
36
X4 Pharmaceuticals
XFOR
$386M
$4.24M 0.35%
11,111
– –
TRVN
37
DELISTED
Trevena, Inc.
TRVN
$3.69M 0.31%
6,099
– –
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.14M 0.26%
3,750,000
– –
PHXM
39
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$2.64M 0.22%
62,500
– –
TCON
40
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.55M 0.13%
17,336
– –
RGLS
41
DELISTED
Regulus Therapeutics
RGLS
$1.48M 0.12%
205,246
– –
ELGX
42
DELISTED
Endologix Inc
ELGX
$989K 0.08%
249,021
– –
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$935K 0.08%
37,094
– –
AKTX
44
Akari Therapeutics
AKTX
$12.9M
$773K 0.06%
565
– –
TRIL
45
DELISTED
Trillium Therapeutics Inc.
TRIL
$646K 0.05%
2,100,000
– –
AKAO
46
DELISTED
Achaogen Inc
AKAO
$63K 0.01%
5,215,128
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q3 2019 Portfolio in Review

As of Q3 2019, NEA Management Company held 46 positions worth $1.21B, down 15% from $1.43B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

NEA Management Company deployed $134M of net new capital in Q3 2019, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Cloudflare: 4,059,376 shares worth $75.4M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

  • NEA Management Company's largest Q3 2019 buy was Cloudflare: 4,059,376 shares worth $75.4M.
  • NEA Management Company added most to Xenon Pharmaceuticals in Q3 2019, an estimated $3.97M increase.
  • NEA Management Company's ten largest holdings make up 69% of its $1.21B portfolio in Q3 2019.
  • NEA Management Company opened 2 new positions and closed 0 in Q3 2019.
  • NEA Management Company's portfolio value fell 15% quarter-over-quarter to $1.21B.

Based on NEA Management Company's 13F filing for Q3 2019, filed 11 Oct 2019.